# Remimazolam Improves the Safety in Elderly Patients Undergoing Gastrointestinal Endoscopy

> **NCT05406102** · PHASE4 · UNKNOWN · sponsor: **First Affiliated Hospital Xi'an Jiaotong University** · enrollment: 300 (estimated)

## Conditions studied

- Anesthetics
- Recovery
- Drug Effect
- Safety
- Psychotropic Drugs
- Anesthetics, Intravenous

## Interventions

- **DRUG:** Remimazolam
- **DRUG:** Propofol group

## Key facts

- **NCT ID:** NCT05406102
- **Lead sponsor:** First Affiliated Hospital Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-10
- **Primary completion:** 2023-05-01
- **Final completion:** 2023-06-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2022-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05406102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05406102, "Remimazolam Improves the Safety in Elderly Patients Undergoing Gastrointestinal Endoscopy". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05406102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*